Advanced Materials Aerospace & defense Agriculture Automation & Process Control Automotive & Transportation Banking & Financial Services Biotechnology Building & Construction Chemicals Cloud Computing Communications Devices and Infrastructure Consumer Goods Country Reports Cyber Security Data Center & Networking Energy Energy Utilities Food & Beverage Global Reports Healthcare Industrial Goods Industry Updates Information and Communications Technology IoT, Bigdata & Digitalization IT & Telecom Medical Devices Mining, Minerals and Metals Networking and Communications Next-Generation Networking Technologies Oil & Gas Outsourcing Services Packaging Pharmaceuticals Regional Reports Semiconductor & Electronics Software & Solutions Technology & Media Travel & Tourism
-
Non-Alcoholic Steatohepatitis Market
The Non-Alcoholic Steatohepatitis Market size was valued at USD 1,179.1 million in 2018 to USD 5,060.1 million in 2024 and is anticipated to reach USD 24,599.0 million by 2032, at a CAGR of 21.83% during the forecast period.
-
Crotonic Acid Market
The Global Crotonic Acid Market size was valued at USD 106.73 million in 2018 to USD 167.30 million in 2024 and is anticipated to reach USD 305.94 million by 2032, at a CAGR of 7.30% during the forecast period.
-
Methotrexate Drugs Market
The Methotrexate drugs market is projected to grow from USD 654.3 million in 2024 to an estimated USD 989 million by 2032, with a compound annual growth rate (CAGR) of 5.3% from 2024 to 2032.
-
Dravet Syndrome Market
The Global Dravet Syndrome Market size was valued at USD 380.0 million in 2018 to USD 488.3 million in 2024 and is anticipated to reach USD 869.2 million by 2032, at a CAGR of 7.50% during the forecast period.
-
Single-Cell Protein Market
The Single Cell Protein Market is projected to grow from USD 10.3 billion in 2024 to USD 19.1 billion by 2032, registering a CAGR of 8% during the forecast period.
-
3D Printed Drugs Market
The 3D Printed Drugs Market was valued at USD 371.4 million in 2024 and is anticipated to reach USD 784.6 million by 2032, expanding at a Compound Annual Growth Rate (CAGR) of 9.8% during the forecast period.
-
Epilepsy Monitoring Devices Market
Epilepsy Monitoring Device Market size was valued at USD 556.7 million in 2024 and is anticipated to reach USD 822.5 million by 2032, at a CAGR of 5% during the forecast period.
-
Transthyretin Amyloidosis Treatment Market
The transthyretin amyloidosis treatment market is projected to grow from USD 6,620 million in 2024 to USD 19,070.4 million by 2032, registering a strong CAGR of 14.14% during the forecast period.
-
Diabetes Diagnostics Market
The diabetes diagnostics market size was valued at USD 36321 million in 2024 and is anticipated to reach USD 61941.2 million by 2032, at a CAGR of 6.9 % during the forecast period (2024-2032).
-
Fibrate Drugs Market
Fibrate Drugs Market size stood at USD 3,572.5 million in 2024 and is projected to reach USD 5,355.1 million by 2032, registering a CAGR of 5.19% during the forecast period.
